Press

Apr
19

Brainwave ‘Balancing’ Research Receives Continued Support From The Susanne Marcus Collins Foundation, Inc.

$620,000 Grant Expands the Scope of Neurological Research

WINSTON-SALEM, N.C. – April 8, 2014 – The Susanne Marcus Collins Foundation, Inc. of Atlanta, Ga., has once again awarded Wake Forest Baptist Medical Center researchers funding to expand clinical studies into the use of a noninvasive, drugless therapy that may help to reduce symptoms associated with a list of neurological conditions.  This year’s grant totals $620,000.

This new grant will fund a controlled clinical research trial for athletes who have had a concussion and suffer from persistent post-concussion symptoms.  Sports-related concussion affects at least 1.3 million Americans each year, many of whom are adolescents or young adults.  While most recover within seven to 10 days, some experience persisting symptoms such as headache; insomnia; poor focus, concentration, or balance; fogginess, irritability, or depression.  Rest is the mainstay of current treatment options, which also includes inner-ear balance therapy or medications for specific symptoms, but new, innovative therapies are sorely needed.

The project is under the direction of Charles H. Tegeler, M.D., McKinney-Avant Professor of Neurology, director of Telestroke Services, and director of the Ward A. Riley Ultrasound Center.  Tegeler is conducting clinical studies of HIRREM (High-resolution, relational, resonance-based, electroencephalic mirroring or, as it’s commercially known, Brainwave Optimization®), a product created by Brain State Technologies, LLC, of Scottsdale, Ariz.  This noninvasive procedure uses a computerized system designed to reflect the brain’s frequencies back to itself in near real time using auditory tones. Resonance between the tones and the electrical circuits in a person’s brain can allow improved balance to the two hemispheres of the brain and has shown reduced symptoms in a pilot study* of people with insomnia.

Preliminary results of Tegeler’s prior studies suggest a reduction in persisting symptoms following sports concussion, or other types of traumatic brain injury, associated with use of HIRREM.  This spring, Tegeler and his colleagues are presenting these results at the 10th World Congress on Brain Injury, and the annual meetings of the American Medical Society for Sports Medicine, and the American Academy of Neurology.

To date, Tegeler’s research has also studied individuals with insomnia, episodic migraine, hot flashes, traumatic brain injury, post-traumatic stress disorder (PTSD), and postural orthostatic tachycardia syndrome (POTS), a condition marked by an unexplained increase in heart rate when standing up, causing dizziness and lightheadedness.  More information on this research can be found at www.wakehealth.edu/HIRREM.

This new grant will also support an ongoing placebo-controlled clinical trial for those with insomnia.  Since 2011, The Susanne Marcus Collins Foundation, Inc. has provided approximately $2.3 million in support of this research. Tegeler awaits receipt of a government grant to evaluate the effect of HIRREM for military personnel with PTSD.

“At a time when funding for research is difficult to find, this support from The Susanne Marcus Collins Foundation, Inc., makes it possible to continue our research program, and the transition to additional controlled clinical trials,” said Tegeler. “We continue our efforts to scientifically evaluate the potential benefits of HIRREM as a noninvasive, non-drug therapy in situations where such options are lacking.  It is with deep gratitude to Susanne Collins that we accept this generous additional funding for this important research, which provides a chance to focus on the important problem of concussion, while continuing our work in those with insomnia.”

*Editor’s note: The pilot study was published in the journal Brain and Behavior in October 2012 (28 OCT 2012, DOI: 10.1002/brb3.101); a methods paper was published in the journal, Brain and Behavior last year (14 JAN 2013, DOI: 10.1002/brb3.116).

Media contacts: Paula Faria, pfaria@wakehealth.edu, 336-716-1279; Mac Ingraham, mingraha@wakehealth.edu, 336-716-3487, or the main office number at 336-716-4587.

Wake Forest Baptist Medical Center (www.wakehealth.edu) is a fully integrated academic medical center located in Winston-Salem, North Carolina. The institution comprises the medical education and research components of Wake Forest School of Medicine, the integrated clinical structure and consumer brand Wake Forest Baptist Health, which includes North Carolina Baptist Hospital and Brenner Children’s Hospital, the creation and commercialization of research discoveries into products that benefit patients and improve health and wellness, through Wake Forest Innovations, as well as a network of affiliated community-based hospitals, physician practices, outpatient services and other medical facilities. Wake Forest School of Medicine is ranked among the nation’s best medical schools and is a leading national research center in fields such as regenerative medicine, cancer, neuroscience, aging, addiction and public health sciences. Wake Forest Baptist’s clinical programs have consistently ranked as among the best in the country by U.S.News & World Report for the past 20 years.

Wake Forest Baptist Medical Center

Communications, Marketing & Media
Medical Center Boulevard  Winston-Salem, NC 27157-1015
Phone: (336) 716-4587 Fax: (336) 716-6841
www.wakehealth.edu/news

Click here to download this press release in PDF format.

Jan
08

A conscious dialogue with Lee Gerdes the Founder and CEO of Brain State Technologies® and the Living Consciously-TV Cast about how to find the goodness in the failures of life. Streamed live by Conscious Evolution Media on 1/7/2014.

Nov
25

SCOTTSDALE, AZ – November 25, 2013 – With the release of BST Optimization Suite 4.2, Brain State Technologies® continues to push the boundaries of the leading system for Brainwave Optimization®. This latest release marks the second system upgrade of 2013 and arrives less than a year since the release of the game-changing version 4.0. Enhancing and expanding the already robust Optimization Suite, version 4.2 reaffirms the preeminence of Brain State Technologies in a fast-moving and ever-growing industry.

Since arriving on the scene in the early 2000’s, Brain State Technologies has remained on the leading edge of brain research and technology. Their patented process for Brainwave Optimization has helped over 50,000 clients world-wide overcome challenges by facilitating relaxation and auto-calibration of the brain. Utilizing a novel approach involving the translation of brainwave activity into musical tones, Brainwave Optimization has caught the attention of national press and prominent neurologists who have praised it as a safe, non-invasive, and non-pharmacological alternative modality.

BST QuoteBST Optimization Suite is the central nervous system of Brainwave Optimization, collecting and analyzing brainwave data, assessing asymmetries, suggesting protocols, and moderating optimization sessions. This system is so advanced and intuitive that the average provider of the technology can be trained and certified as a Brainwave Technologist within a matter of weeks.

Version 4.2 introduces several new features sure to be popular with professional technologists. A new placement/montage selection interface allows technologists greater design flexibility via an intuitive, point-and-click graphical interface. The new Client Report Card presents essential client data in one simple report that makes it easy for any client to see their progress. Finally, new system resilience features have been integrated in version 4.2, offering the greatest benefit to larger, multi-system operations. These new system resilience features will provide greater data-security and failover protection in the event of server and/or network connectivity failures.

The Brain State Technologies technical support and education departments are working overtime to see that the company’s 200+ providers around the world are up to date on the latest software enhancements. System updates and continuing education are provided to all licensed providers at no additional cost. According to Peter Gerdes, Chief Information Officer of Brain State Technologies, "Brainwave Optimization is only as good as the people who provide it. We license the best and give them the tools and the training they need to be their best."

"After all," adds Gerdes, "their clients deserve nothing less than the best."

For additional information, please visit the company’s website, http://www.brainstatetech.com.

 

###

MEDIA NOTE: If you would like more information about Brain State Technologies® or Brainwave Optimization®, please contact Laura Dueker at 480.588.6840 or send an email to pr@brainstatetech.com

About Brain State Technologies (www.brainstatetech.com): Brain State Technologies® is the world’s leading provider of brainwave balancing technology, Brainwave Optimization®. Founded in 2001 and developed by Lee Gerdes, the modality combines the latest advances in neuroscience, neuroplasticity, computer technology, mathematics, and physics. Brainwave Optimization offers a non-invasive way for people of all ages to overcome cognitive, emotional, and physical challenges, and enhance overall performance and wellbeing. With over 50,000 clients and more than 200 affiliated centers in 20 countries, the company is growing by licensing Brainwave Optimization to providers worldwide.

Brain State Technologies®, Brainwave Optimization®, Brainwave Optimization with RTB™, Brain State®, HIRREM®, Intellifier®, Intellipoint®, Intellectrodes™, Intellisensors™, and Braintellect®, are all registered trademarks of Brain State Technologies, LLC. Unauthorized usage is in violation of various countries trademark laws. Brainwave Optimization with RTB® is not intended to treat, cure, heal, or diagnose any disease, mental illness or symptom. Brainwave Optimization with RTB™ is intended to facilitate relaxation and auto-calibration of neural oscillations. Individual results may vary.